Frazier Life Sciences VIII L.P. 13D and 13G filings for Alpine Immune Sciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-05-21 10:21 am Sale | 2024-05-20 | 13D | Alpine Immune Sciences, Inc. ALPN | Frazier Life Sciences VIII L.P. | 0 0.000% | -6,090,980 (Position Closed) | Filing |
| 2024-04-29 6:08 pm Purchase | 2024-04-25 | 13D | Alpine Immune Sciences, Inc. ALPN | Frazier Life Sciences VIII L.P. | 6,090,980 9.300% | 8,079 (+0.13%) | Filing |
| 2023-11-22 10:25 am Purchase | 2023-11-20 | 13D | Alpine Immune Sciences, Inc. ALPN | Frazier Life Sciences VIII L.P. | 6,082,901 9.800% | 2,918,793 (+92.25%) | Filing |
| 2022-02-15 2:18 pm Sale | 2022-02-11 | 13D | Alpine Immune Sciences, Inc. ALPN | Frazier Life Sciences VIII L.P. | 3,164,108 10.800% | -13,734 (-0.43%) | Filing |
| 2021-09-21 3:37 pm Purchase | 2021-09-17 | 13D | Alpine Immune Sciences, Inc. ALPN | Frazier Life Sciences VIII L.P. | 3,177,842 10.000% | 440,741 (+16.10%) | Filing |
| 2020-07-30 8:16 pm Purchase | 2020-07-28 | 13D | Alpine Immune Sciences, Inc. ALPN | Frazier Life Sciences VIII L.P. | 2,737,101 11.500% | 11,475 (+0.42%) | Filing |